Naveen Pemmaraju: Delighted to speak at the MDACC Cancer Network Partner Summit 2024

Naveen Pemmaraju shared a post on Linkedin:

” This week, I was delighted to attend, speak, and moderate two separate sessions (Clinical /Research Engagement – How to Make it Work and Med Onc/Pharmacy Breakfast Breakout Session) at the MDACC Cancer Network Partner Summit 2024 held in Houston.

Shout out to my co-moderators and co-panelists in these sessions – David Warshal, Ryan Roux, Shauna Choi, Michael Overman, Tomislav Dragovich, Laila Samiian, Ana Aparicio, Chad Jaeger and James Yao.

Special thanks to Jeffrey E. Lee, Deborah Kuban, Christina Roland, Grace Abdulmassih, Monica J. de la Cerda, Kathleen Schmeler, Michael Kupferman, Richard Funnell, Sumeet Bhatia, Annette Moore Madappa Kundranda, Matt Ulrickson, Maxim Norkin, Amina Ahmed, Omar Latif, Marc Matrana, Edward Gorak, Zohra Nooruddin, Adolfo de la Fuente Burguera and so many others across the Network for a highly successful event!”

Source: Naveen Pemmaraju/Linkedin

Naveen Pemmaraju is a Professor and Director of BPDCN Program at the Department of Leukemia at the University of Texas MD Anderson Cancer Center (MDACC) and Executive Director of MDACC Network. He is also the Leukemia Hematology/Oncology Course Director. His research work has been focused on improving outcomes and developing novel therapies for patients with rare, and ultra-rare, myeloid malignancies; including adolescents, young adults, and older adult patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), MPN and AML.